Literature DB >> 16109666

Effects of alendronate on bone mass in patients with primary biliary cirrhosis and osteoporosis: preliminary results after one year.

Joanna Musialik1, Michal Petelenz, Zbigniew Gonciarz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16109666     DOI: 10.1080/00365520510023279

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


× No keyword cloud information.
  3 in total

1.  Treatment of osteoporosis in patients with chronic liver disease and in liver transplant recipients.

Authors:  Naim M Maalouf; Khashayar Sakhaee
Journal:  Curr Treat Options Gastroenterol       Date:  2006

Review 2.  Osteoporosis in primary biliary cirrhosis of the liver.

Authors:  Joanna Raszeja-Wyszomirska; Tomasz Miazgowski
Journal:  Prz Gastroenterol       Date:  2014-05-05

Review 3.  Osteoporosis in primary biliary cholangitis.

Authors:  Christopher J Danford; Hirsh D Trivedi; Konstantinos Papamichael; Elliot B Tapper; Alan Bonder
Journal:  World J Gastroenterol       Date:  2018-08-21       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.